Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs

Alessia Greco, Francesca Coperchini, Laura Croce, Flavia Magri, Marsida Teliti, Mario Rotondi · 2023

Read Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs by Alessia Greco, Francesca Coperchini, Laura Croce, Flavia Magri, Marsida Teliti, Mario Rotondi (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10749369.txt.

Description

Alessia Greco and co-authors review whether diabetes drugs could be reused against thyroid cancer. Most thyroid cancer patients fare well, but some tumors resist standard care. Reusing known drugs saves time and cost, since their safety is already mapped. Some diabetes drugs have shown anti-tumor effects in lab work on this cancer.

Not every diabetes drug fits reuse, since side effects rule some out. Three classes stood out with strong effects on thyroid cancer cells. They killed cells, slowed spread, pushed cells back toward a normal type, and reshaped the tumor's local scene. Such mixed action could base paired drug plans. The review weighs the proof drug by drug for future care.

Catalog record

CREATORAlessia Greco, Francesca Coperchini, Laura Croce, Flavia Magri, Marsida Teliti, Mario Rotondi
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10749369

Browse the full library · About the Tower of Babel